New Report on Drug Regulatory Approvals and the Opportunities for Antimicrobial Innovation
A new report by the One Health Trust, Drug Regulatory Approvals and Opportunities for Antimicrobial Innovation – Perspectives from Brazil, India and South Africa, describes the current climate for antimicrobial innovation, focusing on regulatory pathways supporting accelerated drug approvals in Brazil, India, and South Africa.
Produced with the support of the AMR Industry Alliance, the report highlights the importance of explicitly recognizing new antimicrobials targeting serious or life-threatening infections as a critical unmet medical need and formalizing their inclusion in regulatory frameworks for accelerated drug approval.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.